Your browser doesn't support javascript.
loading
A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY).
Geremia, Nicholas; Sanson, Gianfranco; Principe, Luigi; Antonello, Roberta Maria; Zerbato, Verena; Luzzati, Roberto; Di Bella, Stefano.
Afiliação
  • Geremia N; Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale "Dell'Angelo", 30174, Venice, Italy; Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale Civile "S.S. Giovanni e Paolo", 30122, Venice, Italy. Electronic address: nich.geremia@gmail.com.
  • Sanson G; Clinical Department of Medical, Surgical and Health Sciences, University of Trieste, 34127, Trieste, Italy.
  • Principe L; Microbiology and Virology Unit, Great Metropolitan Hospital "Bianchi-Melacrino-Morelli", 89128, Reggio Calabria, Italy. Electronic address: luigi.principe@gmail.com.
  • Antonello RM; Department of Experimental and Clinical Medicine, University of Florence, 50121, Florence, Italy. Electronic address: rma.roby@gmail.com.
  • Zerbato V; Infectious Diseases Unit, Trieste University Hospital, 34128, Trieste, Italy. Electronic address: verena.zerbato@gmail.com.
  • Luzzati R; Clinical Department of Medical, Surgical and Health Sciences, University of Trieste, 34127, Trieste, Italy. Electronic address: roberto.luzzati@asugi.sanita.fvg.it.
  • Di Bella S; Clinical Department of Medical, Surgical and Health Sciences, University of Trieste, 34127, Trieste, Italy. Electronic address: stefano932@gmail.com.
Anaerobe ; 90: 102901, 2024 Aug 28.
Article em En | MEDLINE | ID: mdl-39214165
ABSTRACT
Clostridium perfingens bloodstream infections (BSIs) can be associated with high mortality rates. We performed a subanalysis of all C. perfringens BSIs enrolled during a multicentric retrospective observational study (ITANAEROBY). Data were collected from January 2016 to December 2020. C. perfringens BSIs were 134 (134/1960, 6.8 %). The highest resistance rate was observed for clindamycin (26/120, 21.6 %), penicillin (11/71, 15.4 %) and metronidazole (14/131, 10.7 %). In conclusion, C. perfringens reduced susceptibility phenotype to first-line therapy.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article